Home LiteratureArticle Details
PMID: 18627247 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner.

Human gene therapy ·Vol. 19 ·No. 8 ·2008-08-00 ·Pages 840-50

Hager S, Frame FM, Collins AT, Burns JE, Maitland NJ

Abstract

In lentiviral gene delivery systems, transgene expression cassettes are commonly cloned without a polyadenylation signal to prevent disruption of full-length lentiviral genomes on mRNA maturation in producer cells. The lack of the polyadenylation signal, however, has the potential to reduce stability and translation efficiency of transgene mRNA. Therefore, we have assessed the effect of a strong internal polyadenylation [poly(A)] signal on both transgene expression levels in virus-infected cells and functional viral titer, in a series of eight self-inactivating lentiviruses expressing the mOrange transgene under the control of the constitutive cytomegalovirus (CMV), elongation factor 1alpha (EF1alpha), and beta-actin promoters or the highly tissue-specific prostate-specific antigen/probasin hybrid (PSA/Pb) promoter with or without a simian virus 40 (SV40) early polyadenylation signal downstream of the mOrange-coding sequence. We show that mOrange expression levels in virus-infected HEK-293, LNCaP, and primary prostate epithelial cells were increased 3- to 6.5-fold when an internal polyadenylation signal was present. When the CMV and EF1alpha promoters were used, functional viral titer decreased 8- to 9-fold in the presence of the polyadenylation signal, but titer was not affected when transgene expression was driven by the beta-actin promoter or tissue-specific PSA/Pb promoter. We therefore conclude that an internal polyadenylation signal in lentiviral vectors has a highly beneficial effect on transgene expression, but reduces viral titer in a promoter-dependent manner.

MeSH Terms
Cell Line, Tumor Gene Expression Genes, Reporter Genetic Therapy Genetic Vectors/genetics Genome, Viral Humans Lentivirus/genetics Male Polyadenylation Promoter Regions, Genetic Prostatic Neoplasms/therapy RNA, Messenger/metabolism Transduction, Genetic/methods Transgenes
Chemicals
RNA, Messenger
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hager Stefanie
YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom.
Frame Fiona M
Collins Anne T
Burns Julie E
Maitland Norman J
Article Info
Journal
Human gene therapy
Abbr.
Hum Gene Ther
ISSN
1557-7422
Published
2008-08-00
Pages
840-50
Language
English
Region
United States
NLM ID
9008950
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com